Healthcare >> CEO Interviews >> October 17, 2003
GERALD E. BISBEE JR. has been Chairman, President and Chief Executive
Officer of ReGen Biologics, Inc., since September 1998. Prior to ReGen,
Dr. Bisbee was Chairman and CEO of APACHE Medical Systems, Inc., a
company providing clinical trial and FDA advisory services to device and
pharmaceutical companies, and offering an industry-leading information
management system for high-cost, high-risk patients. Prior to APACHE,
Dr. Bisbee was Chairman and CEO of Sequel Corporation, an orthopedic
rehabilitation practice management and manufacturing company. Dr. Bisbee
holds a PhD from Yale University in chronic disease epidemiology with an
emphasis in musculo-skeletal disease. His dissertation is part of the
development of DRGs. Dr. Bisbee is a co-author of the first national
orthopedic study entitled, Musculoskeletal Disorders: Their Frequency of
Occurrence and Their Impact on the Population of the United States. He
holds an MBA from University of Pennsylvania's Wharton School. Dr.
Bisbee is a Director of Cerner Corporation and HealthGate Data
Corporation. Profile
Dr. Bisbee: ReGen is in the orthopedic products business with a focus on
identifying and developing products for unmet
